AST(SGOT)/ALT(SGPT 0 18 0 18 B-clinical_variable
) 18 19 18 19 I-clinical_variable
≤ 20 21 20 21 O
2.5 22 25 22 25 B-upper_bound
× 26 27 26 27 I-upper_bound
ULN 28 31 28 31 I-upper_bound

Age 0 3 32 35 B-age
≥ 4 5 36 37 O
18 6 8 38 40 B-lower_bound
at 9 11 41 43 O
the 12 15 44 47 O
time 16 20 48 52 O
of 21 23 53 55 O
enrollment 24 34 56 66 O

Creatinine 0 10 67 77 B-clinical_variable
≤ 11 12 78 79 O
1.5 13 16 80 83 B-upper_bound
× 17 18 84 85 I-upper_bound
ULN 19 22 86 89 I-upper_bound
or 23 25 90 92 O
creatinine 26 36 93 103 B-clinical_variable
clearance 37 46 104 113 I-clinical_variable
≥ 47 48 114 115 O
60 49 51 116 118 B-lower_bound
mL 52 54 119 121 I-lower_bound
/ 54 55 121 122 I-lower_bound
min/1.73 55 63 122 130 I-lower_bound
m2 64 66 131 133 I-lower_bound

ECOG 0 4 134 138 B-clinical_variable
performance 5 16 139 150 I-clinical_variable
status 17 23 151 157 I-clinical_variable
≤2 24 26 158 160 O

FEV1 0 4 161 165 B-clinical_variable
and 5 8 166 169 O
DLCO 9 13 170 174 B-clinical_variable
( 14 15 175 176 O
adjusted 15 23 176 184 O
for 24 27 185 188 O
Hemoglobin 28 38 189 199 B-clinical_variable
) 38 39 199 200 O
≥ 40 41 201 202 O
50 42 44 203 205 B-lower_bound
% 44 45 205 206 I-lower_bound
predicted 46 55 207 216 I-lower_bound

HIV 0 3 217 220 B-chronic_disease
- 3 4 220 221 O
positive 4 12 221 229 O

Has 0 3 230 233 O
a 4 5 234 235 O
history 6 13 236 243 O
of 14 16 244 246 O
( 17 18 247 248 O
non 18 21 248 251 O
- 21 22 251 252 O
infectious 22 32 252 262 O
) 32 33 262 263 O
pneumonitis 34 45 264 275 B-chronic_disease
that 46 50 276 280 O
required 51 59 281 289 O
steroids 60 68 290 298 B-treatment
or 69 71 299 301 O
current 72 79 302 309 O
pneumonitis 80 91 310 321 O

Hemoglobin 0 10 322 332 B-clinical_variable
≥ 11 12 333 334 O
8 13 14 335 336 B-lower_bound
g 15 16 337 338 I-lower_bound
/ 16 17 338 339 I-lower_bound
dl 17 19 339 341 I-lower_bound

History 0 7 342 349 O
of 8 10 350 352 O
allergic 11 19 353 361 O
reactions 20 29 362 371 O
attributed 30 40 372 382 O
to 41 43 383 385 O
compounds 44 53 386 395 O
of 54 56 396 398 O
similar 57 64 399 406 O
chemical 65 73 407 415 O
or 74 76 416 418 O
biologic 77 85 419 427 O
composition 86 97 428 439 O
to 98 100 440 442 O
pembrolizumab 101 114 443 456 B-allergy_name

History 0 7 457 464 O
of 8 10 465 467 O
or 11 13 468 470 O
active 14 20 471 477 O
autoimmune 21 31 478 488 B-chronic_disease
disease 32 39 489 496 I-chronic_disease
, 39 40 496 497 O
or 41 43 498 500 O
other 44 49 501 506 O
syndrome 50 58 507 515 O
that 59 63 516 520 O
requires 64 72 521 529 O
systemic 73 81 530 538 B-treatment
steroids 82 90 539 547 I-treatment
or 91 93 548 550 O
autoimmune 94 104 551 561 B-treatment
agents 105 111 562 568 I-treatment

No 0 2 569 571 O
more 3 7 572 576 O
than 8 12 577 581 O
1 13 14 582 583 B-lower_bound
line 15 19 584 588 O
of 20 22 589 591 O
anthracycline 23 36 592 605 B-treatment
- 36 37 605 606 I-treatment
containing 37 47 606 616 I-treatment
chemotherapy 48 60 617 629 I-treatment
prior 61 66 630 635 B-treatment
to 67 69 636 638 I-treatment
ASCT 70 74 639 643 I-treatment
, 74 75 643 644 O
and 76 79 645 648 O
no 80 82 649 651 O
more 83 87 652 656 O
than 88 92 657 661 O
3 93 94 662 663 B-lower_bound
lines 95 100 664 669 O
of 101 103 670 672 O
therapy 104 111 673 680 O
total 112 117 681 686 O
prior 118 123 687 692 O
to 124 126 693 695 O
ASCT 127 131 696 700 O
for 132 135 701 704 O
arms 136 140 705 709 O
A 141 142 710 711 O
and 143 146 712 715 O
B 147 148 716 717 O
; 148 149 717 718 O
no 150 152 719 721 O
more 153 157 722 726 O
than 158 162 727 731 O
1 163 164 732 733 O
line 165 169 734 738 O
of 170 172 739 741 O
therapy 173 180 742 749 O
prior 181 186 750 755 O
to 187 189 756 758 O
ASCT 190 194 759 763 O
for 195 198 764 767 O
arm 199 202 768 771 O
C 203 204 772 773 O

Participants 0 12 774 786 O
can 13 16 787 790 O
not 16 19 790 793 O
have 20 24 794 798 O
received 25 33 799 807 O
any 34 37 808 811 O
anti 38 42 812 816 B-treatment
- 42 43 816 817 I-treatment
neoplastic 43 53 817 827 I-treatment
therapy 54 61 828 835 I-treatment
( 62 63 836 837 O
including 63 72 837 846 O
radiotherapy 73 85 847 859 B-treatment
, 85 86 859 860 O
chemotherapy 87 99 861 873 B-treatment
or 100 102 874 876 O
immunotherapy 103 116 877 890 B-treatment
) 116 117 890 891 O
after 118 123 892 897 O
ASCT 124 128 898 902 B-treatment

Participants 0 12 903 915 O
must 13 17 916 920 O
be 18 20 921 923 O
planning 21 29 924 932 O
to 30 32 933 935 O
receive 33 40 936 943 O
or 41 43 944 946 O
have 44 48 947 951 O
received 49 57 952 960 O
autologous 58 68 961 971 B-treatment
stem 69 73 972 976 I-treatment
cell 74 78 977 981 I-treatment
transplantation 79 94 982 997 I-treatment

Participants 0 12 998 1010 O
must 13 17 1011 1015 O
begin 18 23 1016 1021 O
study 24 29 1022 1027 O
treatment 30 39 1028 1037 B-treatment
no 40 42 1038 1040 O
later 43 48 1041 1046 O
than 49 53 1047 1051 O
21 54 56 1052 1054 B-upper_bound
days 57 61 1055 1059 I-upper_bound
from 62 66 1060 1064 O
the 67 70 1065 1068 O
post 71 75 1069 1073 B-treatment
- 75 76 1073 1074 I-treatment
ASCT 76 80 1074 1078 I-treatment
discharge 81 90 1079 1088 O

Participants 0 12 1089 1101 O
must 13 17 1102 1106 O
have 18 22 1107 1111 O
chemosensitive 23 37 1112 1126 B-chronic_disease
disease 38 45 1127 1134 I-chronic_disease
prior 46 51 1135 1140 I-chronic_disease
to 52 54 1141 1143 O
ASCT 55 59 1144 1148 B-treatment
, 59 60 1148 1149 O
defined 61 68 1150 1157 O
as 69 71 1158 1160 O
achieving 72 81 1161 1170 O
at 82 84 1171 1173 O
least 85 90 1174 1179 O
a 91 92 1180 1181 O
partial 93 100 1182 1189 O
remission 101 110 1190 1199 O
( 111 112 1200 1201 O
as 112 114 1201 1203 O
determined 115 125 1204 1214 O
with 126 130 1215 1219 O
PET 131 134 1220 1223 B-treatment
imaging 135 142 1224 1231 I-treatment
) 142 143 1231 1232 O
to 144 146 1233 1235 O
salvage 147 154 1236 1243 B-treatment
treatment 155 164 1244 1253 I-treatment
. 164 165 1253 1254 O
Participants 166 178 1255 1267 O
with 179 183 1268 1272 O
cHL 184 187 1273 1276 B-cancer
or 188 190 1277 1279 O
DLBCL 191 196 1280 1285 B-cancer
( 197 198 1286 1287 O
arms 198 202 1287 1291 O
A 203 204 1292 1293 O
and 205 208 1294 1297 O
B 209 210 1298 1299 O
) 210 211 1299 1300 O
transplanted 212 224 1301 1313 O
in 225 227 1314 1316 O
1st 228 231 1317 1320 O
remission 232 241 1321 1330 O
after 242 247 1331 1336 O
only 248 252 1337 1341 O
one 253 256 1342 1345 O
line 257 261 1346 1350 O
of 262 264 1351 1353 O
treatment 265 274 1354 1363 O
are 275 278 1364 1367 O
not 279 282 1368 1371 O
eligible 283 291 1372 1380 O

Participants 0 12 1381 1393 O
must 13 17 1394 1398 O
have 18 22 1399 1403 O
had 23 26 1404 1407 O
PET 27 30 1408 1411 B-treatment
- 30 31 1411 1412 I-treatment
CT 31 33 1412 1414 I-treatment
for 34 37 1415 1418 O
restaging 38 47 1419 1428 O
after 48 53 1429 1434 O
salvage 54 61 1435 1442 B-treatment
therapy 62 69 1443 1450 I-treatment
and 70 73 1451 1454 O
before 74 80 1455 1461 O
ASCT 81 85 1462 1466 B-treatment

Participants 0 12 1467 1479 O
who 13 16 1480 1483 O
are 17 20 1484 1487 O
receiving 21 30 1488 1497 O
any 31 34 1498 1501 O
other 35 40 1502 1507 O
investigational 41 56 1508 1523 B-treatment
agents 57 63 1524 1530 I-treatment
after 64 69 1531 1536 O
ASCT 70 74 1537 1541 B-treatment

Participants 0 12 1542 1554 O
who 13 16 1555 1558 O
entered 17 24 1559 1566 O
clinical 25 33 1567 1575 O
remission 34 43 1576 1585 O
with 44 48 1586 1590 O
one 49 52 1591 1594 O
of 53 55 1595 1597 O
those 56 61 1598 1603 O
agents 62 68 1604 1610 O
and 69 72 1611 1614 O
proceeded 73 82 1615 1624 O
to 83 85 1625 1627 O
ASCT 86 90 1628 1632 B-treatment
without 91 98 1633 1640 O
intervening 99 110 1641 1652 O
relapse 111 118 1653 1660 O
may 119 122 1661 1664 O
be 123 125 1665 1667 O
eligible 126 134 1668 1676 O
after 135 140 1677 1682 O
discussion 141 151 1683 1693 O
with 152 156 1694 1698 O
the 157 160 1699 1702 O
Study 161 166 1703 1708 O
Chair 167 172 1709 1714 O

Participants 0 12 1715 1727 O
with 13 17 1728 1732 O
PTCL 18 22 1733 1737 B-treatment
( 23 24 1738 1739 I-treatment
arm 24 27 1739 1742 I-treatment
C 28 29 1743 1744 I-treatment
) 29 30 1744 1745 I-treatment
transplanted 31 43 1746 1758 I-treatment
beyond 44 50 1759 1765 I-treatment
1st 51 54 1766 1769 I-treatment
remission 55 64 1770 1779 I-treatment
are 65 68 1780 1783 O
also 69 73 1784 1788 O
not 74 77 1789 1792 O
eligible 78 86 1793 1801 O

Participants 0 12 1802 1814 O
with 13 17 1815 1819 O
active 18 24 1820 1826 B-chronic_disease
viral 25 30 1827 1832 I-chronic_disease
hepatitis 31 40 1833 1842 I-chronic_disease
( 41 42 1843 1844 O
positive 42 50 1844 1852 O
HepB 51 55 1853 1857 B-chronic_disease
sAg 56 59 1858 1861 O
, 59 60 1861 1862 O
positive 61 69 1863 1871 O
HepB 70 74 1872 1876 O
core 75 79 1877 1881 O
Ab 80 82 1882 1884 O
with 83 87 1885 1889 O
positive 88 96 1890 1898 O
HepB 97 101 1899 1903 O
viral 102 107 1904 1909 O
load 108 112 1910 1914 O
, 112 113 1914 1915 O
or 114 116 1916 1918 O
positive 117 125 1919 1927 O
HepC 126 130 1928 1932 B-chronic_disease
antibody 131 139 1933 1941 O
with 140 144 1942 1946 O
positive 145 153 1947 1955 O
HepC 154 158 1956 1960 O
viral 159 164 1961 1966 O
load 165 169 1967 1971 O
) 169 170 1971 1972 O

Participants 0 12 1973 1985 O
with 13 17 1986 1990 O
vitiligo 18 26 1991 1999 B-chronic_disease
, 26 27 1999 2000 O
resolved 28 36 2001 2009 O
childhood 37 46 2010 2019 O
asthma 47 53 2020 2026 B-chronic_disease
or 54 56 2027 2029 O
atopy 57 62 2030 2035 B-chronic_disease
, 62 63 2035 2036 O
hypothyroidism 64 78 2037 2051 B-chronic_disease
, 78 79 2051 2052 O
or 80 82 2053 2055 O
Sjogren 83 90 2056 2063 B-chronic_disease
's 90 92 2063 2065 I-chronic_disease
syndrome 93 101 2066 2074 I-chronic_disease
, 101 102 2074 2075 O
as 103 105 2076 2078 O
well 106 110 2079 2083 O
as 111 113 2084 2086 O
participants 114 126 2087 2099 O
requiring 127 136 2100 2109 O
only 137 141 2110 2114 O
intranasal 142 152 2115 2125 B-treatment
steroids 153 161 2126 2134 I-treatment
, 161 162 2134 2135 O
intermittent 163 175 2136 2148 O
use 176 179 2149 2152 O
of 180 182 2153 2155 O
bronchodilators 183 198 2156 2171 B-treatment
, 198 199 2171 2172 O
local 200 205 2173 2178 B-treatment
steroid 206 213 2179 2186 I-treatment
injections 214 224 2187 2197 I-treatment
, 224 225 2197 2198 O
or 226 228 2199 2201 O
physiologic 229 240 2202 2213 B-treatment
replacement 241 252 2214 2225 I-treatment
doses 253 258 2226 2231 I-treatment
of 259 261 2232 2234 I-treatment
prednisone 262 272 2235 2245 I-treatment
( 273 274 2246 2247 O
≤ 274 275 2247 2248 O
10 276 278 2249 2251 B-upper_bound
mg 279 281 2252 2254 I-upper_bound
/ 281 282 2254 2255 I-upper_bound
d 282 283 2255 2256 I-upper_bound
) 283 284 2256 2257 O
are 285 288 2258 2261 O
not 289 292 2262 2265 O
excluded 293 301 2266 2274 O
from 302 306 2275 2279 O
this 307 311 2280 2284 O
study 312 317 2285 2290 O

Pregnant 0 8 2291 2299 B-pregnancy
or 9 11 2300 2302 O
lactating 12 21 2303 2312 O
women 22 27 2313 2318 B-gender

Prior 0 5 2319 2324 O
hypersensitivity 6 22 2325 2341 O
reactions 23 32 2342 2351 O
to 33 35 2352 2354 O
anti 36 40 2355 2359 B-allergy_name
- 40 41 2359 2360 I-allergy_name
CD20 41 45 2360 2364 I-allergy_name
therapy 46 53 2365 2372 I-allergy_name
or 54 56 2373 2375 O
anti 57 61 2376 2380 B-allergy_name
- 61 62 2380 2381 I-allergy_name
CD30 62 66 2381 2385 I-allergy_name
therapy 67 74 2386 2393 I-allergy_name
is 75 77 2394 2396 O
not 78 81 2397 2400 O
an 82 84 2401 2403 O
exclusion 85 94 2404 2413 O
criterion 95 104 2414 2423 O

Prior 0 5 2424 2429 B-treatment
treatment 6 15 2430 2439 I-treatment
with 16 20 2440 2444 I-treatment
an 21 23 2445 2447 I-treatment
anti 24 28 2448 2452 I-treatment
PD-1 29 33 2453 2457 I-treatment
, 33 34 2457 2458 I-treatment
anti 35 39 2459 2463 I-treatment
PD 40 42 2464 2466 I-treatment
- 42 43 2466 2467 I-treatment
L1 43 45 2467 2469 I-treatment
, 45 46 2469 2470 I-treatment
or 47 49 2471 2473 I-treatment
anti 50 54 2474 2478 I-treatment
CTLA-4 55 61 2479 2485 I-treatment
agent 62 67 2486 2491 I-treatment

Receipt 0 7 2492 2499 O
of 8 10 2500 2502 O
> 11 12 2503 2504 O
600 13 16 2505 2508 B-lower_bound
mg 17 19 2509 2511 I-lower_bound
/ 19 20 2511 2512 I-lower_bound
m2 20 22 2512 2514 I-lower_bound
total 23 28 2515 2520 B-clinical_variable
dose 29 33 2521 2525 I-clinical_variable
of 34 36 2526 2528 I-clinical_variable
BCNU 37 41 2529 2533 I-clinical_variable
with 42 46 2534 2538 O
prior 47 52 2539 2544 B-treatment
treatments 53 63 2545 2555 I-treatment
including 64 73 2556 2565 O
transplant 74 84 2566 2576 B-treatment
conditioning 85 97 2577 2589 I-treatment
regimen 98 105 2590 2597 I-treatment

Receipt 0 7 2598 2605 O
of 8 10 2606 2608 O
a 11 12 2609 2610 O
live 13 17 2611 2615 B-treatment
vaccine 18 25 2616 2623 I-treatment
within 26 32 2624 2630 O
30 33 35 2631 2633 B-upper_bound
days 36 40 2634 2638 I-upper_bound
of 41 43 2639 2641 O
the 44 47 2642 2645 O
start 48 53 2646 2651 O
of 54 56 2652 2654 O
treatment 57 66 2655 2664 B-treatment

Resting 0 7 2665 2672 B-clinical_variable
and 8 11 2673 2676 I-clinical_variable
ambulatory 12 22 2677 2687 I-clinical_variable
oxygen 23 29 2688 2694 I-clinical_variable
saturation 30 40 2695 2705 I-clinical_variable
≥ 41 42 2706 2707 O
94 43 45 2708 2710 B-lower_bound
% 45 46 2710 2711 I-lower_bound
on 47 49 2712 2714 O
room 50 54 2715 2719 O
air 55 58 2720 2723 O

Uncontrolled 0 12 2724 2736 O
illness 13 20 2737 2744 O
including 21 30 2745 2754 O
, 30 31 2754 2755 O
but 32 35 2756 2759 O
not 36 39 2760 2763 O
limited 40 47 2764 2771 O
to 48 50 2772 2774 O
, 50 51 2774 2775 O
ongoing 52 59 2776 2783 O
or 60 62 2784 2786 O
active 63 69 2787 2793 B-chronic_disease
infection 70 79 2794 2803 I-chronic_disease
, 79 80 2803 2804 O
symptomatic 81 92 2805 2816 O
congestive 93 103 2817 2827 B-chronic_disease
heart 104 109 2828 2833 I-chronic_disease
failure 110 117 2834 2841 I-chronic_disease
, 117 118 2841 2842 O
unstable 119 127 2843 2851 B-chronic_disease
angina 128 134 2852 2858 I-chronic_disease
pectoris 135 143 2859 2867 O
, 143 144 2867 2868 O
cardiac 145 152 2869 2876 B-chronic_disease
arrhythmia 153 163 2877 2887 I-chronic_disease
, 163 164 2887 2888 O
or 165 167 2889 2891 O
psychiatric 168 179 2892 2903 B-chronic_disease
illness 180 187 2904 2911 I-chronic_disease
/ 187 188 2911 2912 O
social 188 194 2912 2918 O
situations 195 205 2919 2929 O
that 206 210 2930 2934 O
would 211 216 2935 2940 O
limit 217 222 2941 2946 O
compliance 223 233 2947 2957 O
with 234 238 2958 2962 O
study 239 244 2963 2968 O
requirements 245 257 2969 2981 O
or 258 260 2982 2984 O
pose 261 265 2985 2989 O
excess 266 272 2990 2996 O
risk 273 277 2997 3001 O
to 278 280 3002 3004 O
the 281 284 3005 3008 O
participant 285 296 3009 3020 O
in 297 299 3021 3023 O
the 300 303 3024 3027 O
opinion 304 311 3028 3035 O
of 312 314 3036 3038 O
the 315 318 3039 3042 O
treating 319 327 3043 3051 O
clinician 328 337 3052 3061 O

Willigness 0 10 3062 3072 B-contraception_consent
to 11 13 3073 3075 I-contraception_consent
use 14 17 3076 3079 I-contraception_consent
contraception 18 31 3080 3093 I-contraception_consent

absolute 0 8 3094 3102 B-clinical_variable
neutrophil 9 19 3103 3113 I-clinical_variable
count 20 25 3114 3119 I-clinical_variable
≥ 26 27 3120 3121 O
1,000 28 33 3122 3127 B-lower_bound
/ 33 34 3127 3128 I-lower_bound
mcL 34 37 3128 3131 I-lower_bound

platelets 0 9 3132 3141 B-clinical_variable
≥ 10 11 3142 3143 O
50,000 12 18 3144 3150 B-lower_bound
/ 18 19 3150 3151 I-lower_bound
mcL 19 22 3151 3154 I-lower_bound

they 0 4 3155 3159 O
must 5 9 3160 3164 O
have 10 14 3165 3169 O
recovered 15 24 3170 3179 O
from 25 29 3180 3184 O
ASCT 30 34 3185 3189 B-treatment
toxicities 35 45 3190 3200 O
at 46 48 3201 3203 O
the 49 52 3204 3207 O
time 53 57 3208 3212 O
of 58 60 3213 3215 O
first 61 66 3216 3221 O
study 67 72 3222 3227 B-treatment
treatment 73 82 3228 3237 I-treatment

total 0 5 3238 3243 B-clinical_variable
bilirubin 6 15 3244 3253 I-clinical_variable
≤ 16 17 3254 3255 O
1.5 18 21 3256 3259 B-upper_bound
× 22 23 3260 3261 I-upper_bound
institutional 24 37 3262 3275 I-upper_bound
upper 38 43 3276 3281 I-upper_bound
limit 44 49 3282 3287 I-upper_bound
of 50 52 3288 3290 I-upper_bound
normal 53 59 3291 3297 I-upper_bound
( 60 61 3298 3299 I-upper_bound
ULN 61 64 3299 3302 I-upper_bound
) 64 65 3302 3303 I-upper_bound
, 65 66 3303 3304 O
or 67 69 3305 3307 O
direct 70 76 3308 3314 B-clinical_variable
bilirubin 77 86 3315 3324 I-clinical_variable
≤ 87 88 3325 3326 O
ULN 89 92 3327 3330 O
in 93 95 3331 3333 O
patients 96 104 3334 3342 O
with 105 109 3343 3347 O
Gilbert 110 117 3348 3355 B-chronic_disease
's 117 119 3355 3357 I-chronic_disease
syndrome 120 128 3358 3366 I-chronic_disease

